Risankizumab
Products in Health Canada’s databases that list Risankizumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 7
- 6 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 21
- Products in all
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| SKYRIZI (150 MG) | 02519283 | Marketed | AbbVie Corporation | |
| SKYRIZI (150 MG) | 02519291 | Marketed | AbbVie Corporation | |
| SKYRIZI (360 MG) | 02532093 | Marketed | AbbVie Corporation | |
| SKYRIZI (60 MG) | 02532107 | Marketed | AbbVie Corporation | |
| SKYRIZI (180 MG) | 02552507 | Marketed | AbbVie Corporation | |
| SKYRIZI (90 MG) | 02546922 | Approved | AbbVie Corporation | |
| SKYRIZI (75 MG) | 02487454 | Cancelled Post Market | AbbVie Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SKYRIZIJuly 29, 2026 · NOC 38006
- SKYRIZIJuly 10, 2026 · NOC 37870
- SKYRIZIJuly 8, 2026 · NOC 37857
- SKYRIZINovember 17, 2025 · NOC 36385
- SKYRIZIJune 30, 2025 · NOC 35728
- SKYRIZIJune 17, 2025 · NOC 35536
- SKYRIZIJune 4, 2025 · NOC 35482
- SKYRIZIDecember 18, 2024 · NOC 34586
- SKYRIZIDecember 17, 2024 · NOC 34579
- SKYRIZIOctober 10, 2024 · NOC 34213
- SKYRIZISeptember 13, 2024 · NOC 34024
- SKYRIZIApril 5, 2024 · NOC 33017
- SKYRIZIMay 15, 2023 · NOC 30756
- SKYRIZIJanuary 25, 2023 · NOC 29977
- SKYRIZIOctober 19, 2022 · NOC 29238
- SKYRIZIMay 4, 2022 · NOC 28087
- SKYRIZIMarch 16, 2022 · NOC 27778
- SKYRIZIAugust 19, 2021 · NOC 26479
- SKYRIZIJune 2, 2021 · NOC 25958
- SKYRIZISeptember 24, 2020 · NOC 24312
- SKYRIZIApril 17, 2019 · NOC 22070